TIEDRE PALMER: Open Payments
NPI 1144679051 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 74 payments from 19 companies in 2025. Trend: 2023 $798 · 2024 $964 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $451 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $254 |
| Ardelyx, Inc. | 5 | $201 |
| Novo Nordisk Inc | 3 | $194 |
| Regeneron Healthcare Solutions, Inc. | 2 | $155 |
| Phathom Pharmaceuticals, Inc. | 8 | $93 |
| GENZYME CORPORATION | 4 | $91 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Madrigal Pharmaceuticals | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
Products named: XIFAXAN, DUPIXENT, RINVOQ, IBSRELA, Wegovy, VOQUEZNA, CREON, ZENPEP.
Industry payments across NC — which companies pay providers there.
